Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;3(1):23.
doi: 10.1186/s40348-016-0051-9. Epub 2016 Jun 29.

Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development

Affiliations
Review

Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development

Tayyab Shahzad et al. Mol Cell Pediatr. 2016 Dec.

Abstract

Bronchopulmonary dysplasia is a chronic lung disease of preterm infants. It is caused by the disturbance of physiologic lung development mainly in the saccular stage with lifelong restrictions of pulmonary function and an increased risk of abnormal somatic and psychomotor development. The contributors to this disease's entity are multifactorial with pre- and postnatal origin. Central to the pathogenesis of bronchopulmonary is the induction of a massive pulmonary inflammatory response due to mechanical ventilation and oxygen toxicity. The extent of the pro-inflammatory reaction and the disturbance of further alveolar growth and vasculogenesis vary largely and can be modified by prenatal infections, antenatal steroids, and surfactant application.This minireview summarizes the important recent research findings on the pulmonary inflammatory reaction obtained in patient cohorts and in experimental models. Unfortunately, recent changes in clinical practice based on these findings had only limited impact on the incidence of bronchopulmonary dysplasia.

Keywords: Alveologenesis; Antenatal steroids; Apoptosis; Bronchopulmonary dysplasia; Chronic lung disease of the preterm infant; Infection; Inflammation; Lung development; Surfactant; Vasculogenesis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Central risk factors for BPD development. Depicted are the central pre-/perinatal and postnatal risk factors contributing to the pathogenesis of BPD
Fig. 2
Fig. 2
Pathogenesis of BPD: impact of the pulmonary inflammatory response on the premature lung. The scheme summarizes the effects of the pulmonary inflammatory response on alveolar and vascular development and the central components of lung development in the mesenchymal interstitium

References

    1. Gortner L, Misselwitz B. Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: results from the MOSAIC cohort. Neonatology. 2011;99:112–117. doi: 10.1159/000313024. - DOI - PubMed
    1. Islam JA, Keller RL, Aschner JL, Hartert TV, Moore PE, et al. Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia. Am J Respir Crit Care Med. 2015;192(2):134–156. doi: 10.1164/rccm.201412-2142PP. - DOI - PMC - PubMed
    1. Didon L, Roos AB, Elmberger GP, Gonzalez FJ, Nord M, et al. Lung-specific inactivation of CCAAT/enhancer binding protein a causes a pathological pattern characteristic of COPD. Eur Respir J. 2010;35(1):186–197. doi: 10.1183/09031936.00185008. - DOI - PMC - PubMed
    1. Carraro S, Giordano G, Pirillo P, Maretti M, Reniero F, Cogo PE, Perilongo G, Stocchero M, Baraldi E, et al. Airway metabolic anomalies in adolescents with bronchopulmonary dysplasia: new insights from the metabolomic approach. J Pediatr. 2015;166(2):234–239. doi: 10.1016/j.jpeds.2014.08.049. - DOI - PubMed
    1. Suursalmi P, Kopeli T, Korhonen P, Lehtimäki L, Nieminen R, Luukkaala T, Moilanen E, Korppi M, Paassilta M, Tammela O, et al. Very low birthweight bronchopulmonary dysplasia survivors show no substantial association between lung function and current inflammatory markers. Acta Paediatr. 2015;104(3):264–268. doi: 10.1111/apa.12837. - DOI - PubMed

LinkOut - more resources